Mycobacterial trehalose dimycolate reprograms macrophage global gene expression and activates matrix metalloproteinases

Infection and Immunity

Volumn 81, Issue 3, 2013, Pages 764-776

  Sakamoto, Kaori ^a   Kim, Mi Jeong ^b   Rhoades, Elizabeth R ^c   Allavena, Rachel E ^d   Ehrt, Sabine ^e   Wainwright, Helen C ^f   Russell, David G ^g   Rohde, Kyle H ^h  

^a UNIVERSITY OF GEORGIA   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Department of Theoretical and Applied Mechanics and the Cornell Nanofabrication Facility   (United States)

^d UNIVERSITY OF QUEENSLAND   (Australia)

^e WEILL CORNELL MEDICAL COLLEGE   (United States)

^f UNIVERSITY OF CAPE TOWN   (South Africa)

^g Animal Health Diagnostic Center   (United States)

^h UNIVERSITY OF CENTRAL FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGENASE 3; CORD FACTOR; CXCL1 CHEMOKINE; CXCL2 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GELATINASE B; INTERLEUKIN 1BETA; MACROPHAGE ELASTASE; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MATRIX METALLOPROTEINASE; MONOCYTE CHEMOTACTIC PROTEIN 3; MONOCYTE CHEMOTACTIC PROTEIN 5; MYELOID DIFFERENTIATION FACTOR 88; NEUTROPHIL COLLAGENASE; TOLL LIKE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; GENE CONTROL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; MACROPHAGE; MOUSE; MYCOBACTERIUM BOVIS; MYCOBACTERIUM TUBERCULOSIS; NEUTROPHIL; NONHUMAN; NUCLEAR REPROGRAMMING; PHAGOCYTOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

ANIMALS; CORD FACTORS; GENE EXPRESSION REGULATION; GRANULOMA; HUMANS; MACROPHAGES; MATRIX METALLOPROTEINASES; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYCOBACTERIUM TUBERCULOSIS; MYELOID DIFFERENTIATION FACTOR 88; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RNA; TRANSCRIPTOME;

EID: 84874748904     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.00906-12     Document Type: Article

References (77)

1. World Health Organization. 2011. Global tuberculosis control. World Health Organization, Geneva, Switzerland.
2. Dannenberg AM, Jr, Sugimoto M. 1976. Liquefaction of caseous foci in tuberculosis. Am. Rev. Respir. Dis. 113:257-259.
3. Witmer G, Fine AE, Gionfriddo J, Pipas M, Shively K, Piccolo K, Burke P. 2010. Epizootiologic survey of Mycobacterium bovis in wildlife and farm environments in northern Michigan. J. Wildl. Dis. 46:368-378.
4. Bekierkunst A. 1968. Acute granulomatous response produced in mice by trehalose-6,6-dimycolate. J. Bacteriol. 96:958-961.
5. Bekierkunst A, Levij IS, Yarkoni E, Vilkas E, Adam A, Lederer E. 1969. Granuloma formation induced in mice by chemically defined mycobacterial fractions. J. Bacteriol. 100:95-102.
6. Retzinger GS, Meredith SC, Takayama K, Hunter RL, Kezdy FJ. 1981. The role of surface in the biological activities of trehalose 6,6=-dimycolate. Surface properties and development of a model system. J. Biol. Chem. 256:8208-8216.
7. Rhoades ER, Geisel RE, Butcher BA, McDonough S, Russell DG. 2005. Cell wall lipids from Mycobacterium bovis BCG are inflammatory when inoculated within a gel matrix: characterization of a new model of the granulomatous response to mycobacterial components. Tuberculosis (Edinb.) 85:159-176.
8. Geisel RE, Sakamoto K, Russell DG, Rhoades ER. 2005. In vivo activity of released cell wall lipids of Mycobacterium bovis bacillus Calmette- Guerin is due principally to trehalose mycolates. J. Immunol. 174:5007-5015.
9. Kim MJ, Wainwright HC, Locketz M, Bekker LG, Walther GB, Dittrich C, Visser A, Wang W, Hsu FF, Wiehart U, Tsenova L, Kaplan G, Russell DG. 2010. Caseation of human tuberculosis granulomas correlates with elevated host lipid metabolism. EMBO Mol. Med. 2:258-274.
10. Parks WC, Wilson CL, Lopez-Boado YS. 2004. Matrix metalloproteinases as modulators of inflammation and innate immunity. Nat. Rev. 4:617-629.
11. Lai WC, Zhou M, Shankavaram U, Peng G, Wahl LM. 2003. Differential regulation of lipopolysaccharide-induced monocyte matrix metalloproteinase (MMP)-1 and MMP-9 by p38 and extracellular signal-regulated kinase 1/2 mitogen-activated protein kinases. J. Immunol. 170:6244-6249.
12. Van Wart HE, Birkedal-Hansen H. 1990. The cysteine switch: a principle of regulation of metalloproteinase activity with potential applicability to the entire matrix metalloproteinase gene family. Proc. Natl. Acad. Sci. U. S. A. 87:5578-5582.
13. Nagase H, Visse R, Murphy G. 2006. Structure and function of matrix metalloproteinases and TIMPs. Cardiovasc. Res. 69:562-573.
14. Visse R, Nagase H. 2003. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ. Res. 92:827-839.
15. Barmina OY, Walling HW, Fiacco GJ, Freije JM, Lopez-Otin C, Jeffrey JJ, Partridge NC. 1999. Collagenase-3 binds to a specific receptor and requires the low density lipoprotein receptor-related protein for internalization. J. Biol. Chem. 274:30087-30093.
16. Fu X, Kassim SY, Parks WC, Heinecke JW. 2003. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. J. Biol. Chem. 278:28403-28409.
17. Rivera-Marrero CA, Schuyler W, Roser S, Roman J. 2000. Induction of MMP-9 mediated gelatinolytic activity in human monocytic cells by cell wall components of Mycobacterium tuberculosis. Microb. Pathog. 29: 231-244.
18. Quiding-Jarbrink M, Smith DA, Bancroft GJ. 2001. Production of matrix metalloproteinases in response to mycobacterial infection. Infect. Immun. 69:5661-5670.
19. Chang JC, Wysocki A, Tchou-Wong KM, Moskowitz N, Zhang Y, Rom WN. 1996. Effect of Mycobacterium tuberculosis and its components on macrophages and the release of matrix metalloproteinases. Thorax 51: 306-311.
20. Hoheisel G, Sack U, Hui DS, Huse K, Chan KS, Chan KK, Hartwig K, Schuster E, Scholz GH, Schauer J. 2001. Occurrence of matrix metalloproteinases and tissue inhibitors of metalloproteinases in tuberculous pleuritis. Tuberculosis (Edinb.) 81:203-209.
21. Park KJ, Hwang SC, Sheen SS, Oh YJ, Han JH, Lee KB. 2005. Expression of matrix metalloproteinase-9 in pleural effusions of tuberculosis and lung cancer. Respiration 72:166-175.
22. Elkington PT, Nuttall RK, Boyle JJ, O'Kane CM, Horncastle DE, Edwards DR, Friedland JS. 2005. Mycobacterium tuberculosis, but not vaccine BCG, specifically upregulates matrix metalloproteinase-1. Am. J. Respir. Crit. Care Med. 172:1596-1604.
23. Elkington P, Shiomi T, Breen R, Nuttall RK, Ugarte-Gil CA, Walker NF, Saraiva L, Pedersen B, Mauri F, Lipman M, Edwards DR, Robertson BD, D'Armiento J, Friedland JS. 2011. MMP-1 drives immunopathology in human tuberculosis and transgenic mice. J. Clin. Invest. 121: 1827-1833.
24. Hrabec E, Strek M, Zieba M, Kwiatkowska S, Hrabec Z. 2002. Circulation level of matrix metalloproteinase-9 is correlated with disease severity in tuberculosis patients. Int. J. Tuberc. Lung Dis. 6:713-719.
25. Volkman HE, Pozos TC, Zheng J, Davis JM, Rawls JF, Ramakrishnan L. 2010. Tuberculous granuloma induction via interaction of a bacterial secreted protein with host epithelium. Science 327:466-469.
26. Takayama K, Schnoes HK, Armstrong EL, Boyle RW. 1975. Site of inhibitory action of isoniazid in the synthesis of mycolic acids in Mycobacterium tuberculosis. J. Lipid Res. 16:308-317.
27. Rhoades E, Hsu F, Torrelles JB, Turk J, Chatterjee D, Russell DG. 2003. Identification and macrophage-activating activity of glycolipids released from intracellular Mycobacterium bovis BCG. Mol. Microbiol. 48:875-888.
28. Wipke BT, Allen PM. 2001. Essential role of neutrophils in the initiation and progression of a murine model of rheumatoid arthritis. J. Immunol. 167:1601-1608.
29. Shi C, Hohl TM, Leiner I, Equinda MJ, Fan X, Pamer EG. 2011. Ly6G+ neutrophils are dispensable for defense against systemic Listeria monocytogenes infection. J. Immunol. 187:5293-5298.
30. Bowdish DM, Sakamoto K, Kim MJ, Kroos M, Mukhopadhyay S, Leifer CA, Tryggvason K, Gordon S, Russell DG. 2009. MARCO, TLR2, and CD14 are required for macrophage cytokine responses to mycobacterial trehalose dimycolate and Mycobacterium tuberculosis. PLoS Pathog. 5:e1000474. doi:10.1371/journal.ppat.1000474.
31. Nan B, Lin P, Lumsden AB, Yao Q, Chen C. 2005. Effects of TNF-alpha and curcumin on the expression of thrombomodulin and endothelial protein C receptor in human endothelial cells. Thromb. Res. 115:417-426.
32. Flynn JL, Goldstein MM, Chan J, Triebold KJ, Pfeffer K, Lowenstein CJ, Schreiber R, Mak TW, Bloom BR. 1995. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice. Immunity 2:561-572.
33. Chen YC, Chin CH, Liu SF, Wu CC, Tsen CC, Wang YH, Chao TY, Lie CH, Chen CJ, Wang CC, Lin MC. 2011. Prognostic values of serum IP-10 and IL-17 in patients with pulmonary tuberculosis. Dis. Markers 31:101-110.
34. Sarkar S, Song Y, Sarkar S, Kipen HM, Laumbach RJ, Zhang J, Strickland PA, Gardner CR, Schwander S. 2012. Suppression of the NFkappaB pathway by diesel exhaust particles impairs human antimycobacterial immunity. J. Immunol. 188:2778-2793.
35. Liu E, Law HK, Lau YL. 2003. BCG promotes cord blood monocytederived dendritic cell maturation with nuclear Rel-B up-regulation and cytosolic I kappa B alpha and beta degradation. Pediatr. Res. 54:105-112.
36. Windish HP, Lin PL, Mattila JT, Green AM, Onuoha EO, Kane LP, Flynn JL. 2009. Aberrant TGF-beta signaling reduces T regulatory cells in ICAM-1-deficient mice, increasing the inflammatory response to Mycobacterium tuberculosis. J. Leukoc. Biol. 86:713-725.
37. Dutta NK, Mehra S, Martinez AN, Alvarez X, Renner NA, Morici LA, Pahar B, Maclean AG, Lackner AA, Kaushal D. 2012. The stressresponse factor SigH modulates the interaction between Mycobacterium tuberculosis and host phagocytes. PLoS One 7:e28958. doi:10.1371/journal.pone.0028958.
38. Schoenen H, Bodendorfer B, Hitchens K, Manzanero S, Werninghaus K, Nimmerjahn F, Agger EM, Stenger S, Andersen P, Ruland J, Brown GD, Wells C, Lang R. 2010. Cutting edge: Mincle is essential for recognition and adjuvanticity of the mycobacterial cord factor and its synthetic analog trehalose-dibehenate. J. Immunol. 184:2756-2760.
39. Ishikawa E, Ishikawa T, Morita YS, Toyonaga K, Yamada H, Takeuchi O, Kinoshita T, Akira S, Yoshikai Y, Yamasaki S. 2009. Direct recognition of the mycobacterial glycolipid, trehalose dimycolate, by C-type lectin Mincle. J. Exp. Med. 206:2879-2888.
40. Bekierkunst A, Yarkoni E, Flechner I, Morecki S, Vilkas E, Lederer E. 1971. Immune response to sheep red blood cells in mice pretreated with mycobacterial fractions. Infect. Immun. 4:256-263.
41. Granger DL, Yamamoto KI, Ribi E. 1976. Delayed hypersensitivity and granulomatous response after immunization with protein antigens associated with a mycobacterial glycolipid and oil droplets. J. Immunol. 116: 482-488.
42. Saito R, Nagao S, Takamoto M, Sugiyama K, Tanaka A. 1977. Adjuvanticity (immunity-inducing property) of cord factor in mice and rats. Infect. Immun. 16:725-729.
43. Saito R, Tanaka A, Sugiyama K, Azuma I, Yamamura Y. 1976. Adjuvant effect of cord factor, a mycobacterial lipid. Infect. Immun. 13:776-781.
44. Yarkoni E, Bekierkunst A. 1976. Nonspecific resistance against infection with Salmonella typhi and Salmonella typhimurium induced in mice by cord factor (trehalose-6,6=-dimycolate) and its analogues. Infect. Immun. 14:1125-1129.
45. Madonna GS, Ledney GD, Elliott TB, Brook I, Ulrich JT, Myers KR, Patchen ML, Walker RI. 1989. Trehalose dimycolate enhances resistance to infection in neutropenic animals. Infect. Immun. 57:2495-2501.
46. Guillemard E, Geniteau-Legendre M, Kergot R, Lemaire G, Petit JF, Labarre C, Quero AM. 1995. Role of trehalose dimycolate-induced interferon- alpha/beta in the restriction of encephalomyocarditis virus growth in vivo and in peritoneal macrophage cultures. Antiviral Res. 28: 175-189.
47. Kierszenbaum F, Zenian A, Wirth JJ. 1984. Macrophage activation by cord factor (trehalose 6,6=-dimycolate): enhanced association with and intracellular killing of Trypanosoma cruzi. Infect. Immun. 43:531-535.
48. Clark IA. 1979. Protection of mice against Babesia microti with cord factor, COAM, zymosan, glucan, Salmonella and Listeria. Parasite Immunol. 1:179-196.
49. Masihi KN, Brehmer W, Lange W, Werner H, Ribi E. 1985. Trehalose dimycolate from various mycobacterial species induces differing antiinfectious activities in combination with muramyl dipeptide. Infect. Immun. 50:938-940.
50. Nilsson R, Bajic VB, Suzuki H, di Bernardo D, Bjorkegren J, Katayama S, Reid JF, Sweet MJ, Gariboldi M, Carninci P, Hayashizaki Y, Hume DA, Tegner J, Ravasi T. 2006. Transcriptional network dynamics in macrophage activation. Genomics 88:133-142.
51. Court N, Vasseur V, Vacher R, Fremond C, Shebzukhov Y, Yeremeev VV, Maillet I, Nedospasov SA, Gordon S, Fallon PG, Suzuki H, Ryffel B, Quesniaux VF. 2010. Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection. J. Immunol. 184:7057-7070.
52. Heitmann L, Schoenen H, Ehlers S, Lang R, Holscher C. Mincle is not essential for controlling Mycobacterium tuberculosis infection. Immunobiology, in press.
53. Chiu BC, Freeman CM, Stolberg VR, Komuniecki E, Lincoln PM, Kunkel SL, Chensue SW. 2003. Cytokine-chemokine networks in experimental mycobacterial and schistosomal pulmonary granuloma formation. Am. J. Respir. Cell Mol. Biol. 29:106-116.
54. Behling CA, Perez RL, Kidd MR, Staton GW, Jr, Hunter RL. 1993. Induction of pulmonary granulomas, macrophage procoagulant activity, and tumor necrosis factor-alpha by trehalose glycolipids. Ann. Clin. Lab. Sci. 23:256-266.
55. Perez RL, Roman J, Roser S, Little C, Olsen M, Indrigo J, Hunter RL, Actor JK. 2000. Cytokine message and protein expression during lung granuloma formation and resolution induced by the mycobacterial cord factor trehalose-6,6=-dimycolate. J. Interferon Cytokine Res. 20:795-804.
56. Actor JK, Indrigo J, Beachdel CM, Olsen M, Wells A, Hunter RL, Jr, Dasgupta A. 2002. Mycobacterial glycolipid cord factor trehalose 6,6=- dimycolate causes a decrease in serum cortisol during the granulomatous response. Neuroimmunomodulation 10:270-282.
57. Hamasaki N, Isowa K, Kamada K, Terano Y, Matsumoto T, Arakawa T, Kobayashi K, Yano I. 2000. In vivo administration of mycobacterial cord factor (trehalose 6,6=-dimycolate) can induce lung and liver granulomas and thymic atrophy in rabbits. Infect. Immun. 68:3704-3709.
58. Silva CL, Faccioli LH. 1988. Tumor necrosis factor (cachectin) mediates induction of cachexia by cord factor from mycobacteria. Infect. Immun. 56:3067-3071.
59. Shi S, Nathan C, Schnappinger D, Drenkow J, Fuortes M, Block E, Ding A, Gingeras TR, Schoolnik G, Akira S, Takeda K, Ehrt S. 2003. MyD88 primes macrophages for full-scale activation by interferon-gamma yet mediates few responses to Mycobacterium tuberculosis. J. Exp. Med. 198: 987-997.
60. Keller C, Lauber J, Blumenthal A, Buer J, Ehlers S. 2004. Resistance and susceptibility to tuberculosis analysed at the transcriptome level: lessons from mouse macrophages. Tuberculosis (Edinb.) 84:144-158.
61. Grassi M, Bocchino M, Marruchella A, Volpe E, Saltini C, Colizzi V, Mariani F. 2006. Transcriptional profile of the immune response in the lungs of patients with active tuberculosis. Clin. Immunol. 121:100-107.
62. Shen Y, Shen L, Sehgal P, Huang D, Qiu L, Du G, Letvin NL, Chen ZW. 2004. Clinical latency and reactivation of AIDS-related mycobacterial infections. J. Virol. 78:14023-14032.
63. Elass E, Aubry L, Masson M, Denys A, Guerardel Y, Maes E, Legrand D, Mazurier J, Kremer L. 2005. Mycobacterial lipomannan induces matrix metalloproteinase-9 expression in human macrophagic cells through a Toll-like receptor 1 (TLR1)/TLR2- and CD14-dependent mechanism. Infect. Immun. 73:7064-7068.
64. Taylor JL, Hattle JM, Dreitz SA, Troudt JM, Izzo LS, Basaraba RJ, Orme IM, Matrisian LM, Izzo AA. 2006. Role for matrix metalloproteinase 9 in granuloma formation during pulmonary Mycobacterium tuberculosis infection. Infect. Immun. 74:6135-6144.
65. Kaneda K, Imaizumi S, Mizuno S, Baba T, Tsukamura M, Yano I. 1988. Structure and molecular species composition of three homologous series of alpha-mycolic acids from Mycobacterium spp. J. Gen. Microbiol. 134: 2213-2229.
66. Hunter RL, Olsen M, Jagannath C, Actor JK. 2006. Trehalose 6,6=- dimycolate and lipid in the pathogenesis of caseating granulomas of tuberculosis in mice. Am. J. Pathol. 168:1249-1261.
67. Harth G, Zamecnik PC, Tabatadze D, Pierson K, Horwitz MA. 2007. Hairpin extensions enhance the efficacy of mycolyl transferase-specific antisense oligonucleotides targeting Mycobacterium tuberculosis. Proc. Natl. Acad. Sci. U. S. A. 104:7199-7204.
68. Harth G, Zamecnik PC, Tang JY, Tabatadze D, Horwitz MA. 2000. Treatment of Mycobacterium tuberculosis with antisense oligonucleotides to glutamine synthetase mRNA inhibits glutamine synthetase activity, formation of the poly-L-glutamate/glutamine cell wall structure, and bacterial replication. Proc. Natl. Acad. Sci. U. S. A. 97:418-423.
69. Belisle JT, Vissa VD, Sievert T, Takayama K, Brennan PJ, Besra GS. 1997. Role of the major antigen of Mycobacterium tuberculosis in cell wall biogenesis. Science 276:1420-1422.
70. Rao V, Fujiwara N, Porcelli SA, Glickman MS. 2005. Mycobacterium tuberculosis controls host innate immune activation through cyclopropane modification of a glycolipid effector molecule. J. Exp. Med. 201:535-543.
71. Barkan D, Hedhli D, Yan HG, Huygen K, Glickman MS. 2012. Mycobacterium tuberculosis lacking all mycolic acid cyclopropanation is viable but highly attenuated and hyperinflammatory in mice. Infect. Immun. 80:1958-1968.
72. Rao V, Gao F, Chen B, Jacobs WR, Jr, Glickman MS. 2006. Transcyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis-induced inflammation and virulence. J. Clin. Invest. 116:1660-1667.
73. Ryan GJ, Hoff DR, Driver ER, Voskuil MI, Gonzalez-Juarrero M, Basaraba RJ, Crick DC, Spencer JS, Lenaerts AJ. 2010. Multiple M. tuberculosis phenotypes in mouse and guinea pig lung tissue revealed by a dual-staining approach. PLoS One 5:e11108. doi:10.1371/journal.pone.0011108.
74. Woessner JF, Jr. 1991. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J. 5:2145-2154.
75. Henriet P, Blavier L, Declerck YA. 1999. Tissue inhibitors of metalloproteinases (TIMP) in invasion and proliferation. APMIS 107:111-119.
76. Nagase H. 1997. Activation mechanisms of matrix metalloproteinases. Biol. Chem. 378:151-160.
77. d'Ortho MP, Stanton H, Butler M, Atkinson SJ, Murphy G, Hembry RM. 1998. MT1-MMP on the cell surface causes focal degradation of gelatin films. FEBS Lett. 421:159-164.